眼ドラッグデリバリーの世界市場レポート 2025年

眼ドラッグデリバリーの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.9％で271億8,000万米ドルに成長します。予測期間における成長の背景には、加齢に伴う眼疾患の罹患率の上昇、眼科における個別化医療の重視、眼科研究への投資の増加、薬剤放出の長期化に対する需要、眼の健康に対する世界の取り組みなどがあります。予測期間における主な動向としては、スマートドラッグデリバリーデバイスの統合、眼科用薬剤製剤における個別化医療、局所眼科治療薬の開発、業界横断的イノベーションのための共同研究などが挙げられます。

眼ドラッグデリバリー市場の予測される成長は、眼疾患の有病率の増加によって推進されると予想されます。眼疾患は、眼球、視力、または眼球周辺構造に影響を及ぼす幅広い症状を包含します。眼ドラッグデリバリーは、薬剤を標的部位に直接送達し、治療効果を最適化し、全身的な副作用を最小限に抑え、様々な眼疾患に対処することで極めて重要な役割を果たしています。例えば、2023年3月に世界保健機関（WHO）が発表した世界推計によると、世界で22億人が近視または遠視の障害を経験するとされています。視覚障害の主な原因としては、白内障（9,400万件）と未矯正の屈折障害（8,840万件）が際立っています。さらに、緑内障（770万症例）、角膜混濁（420万症例）、糖尿病性網膜症（390万症例）、トラコーマ（200万症例）などの疾患が視力喪失に大きく寄与しています。したがって、眼疾患の有病率の増加は、眼ドラッグデリバリー市場成長の主要な促進要因です。

老年人口の増加は、将来の眼ドラッグデリバリー市場の成長を促進すると予測されています。老人人口には通常、65歳以上の高齢者が含まれます。加齢に伴い、加齢黄斑変性、緑内障、白内障などの眼疾患の有病率が上昇します。幸いなことに、眼ドラッグデリバリーの進歩により、高齢者のこれらの疾患に対する効果的な治療法が提供されつつあります。例えば、2024年1月、ケニアに本部を置く非営利団体人口問題研究所は、65歳以上のアメリカ人の数が2022年の5,800万人から2050年には8,200万人になり、47％増加すると予測しました。さらに、この年齢層が総人口に占める割合も、同時期に17％から23％に増加すると予想されています。このように、高齢人口の拡大が眼ドラッグデリバリー市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の眼ドラッグデリバリーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の眼ドラッグデリバリー市場：成長率分析
• 世界の眼ドラッグデリバリー市場の実績：規模と成長, 2019-2024
• 世界の眼ドラッグデリバリー市場の予測：規模と成長, 2024-2029, 2034F
• 世界の眼ドラッグデリバリー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の眼ドラッグデリバリー市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 埋め込み型眼ドラッグデリバリーシステム
• 微粒子ドラッグデリバリーシステム
• ナノ粒子ドラッグデリバリーシステム
• その他の技術
• 世界の眼ドラッグデリバリー市場：製剤別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リポソームとナノ粒子
• ソリューション
• 乳剤
• サスペンション
• 軟膏
• 世界の眼ドラッグデリバリー市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 緑内障
• 糖尿病網膜症
• ドライアイ症候群
• 黄斑変性症
• 白内障
• 糖尿病黄斑浮腫
• その他の疾患
• 世界の眼ドラッグデリバリー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 眼科クリニック
• 外来手術センター
• 世界の眼ドラッグデリバリー市場、タイプ別サブセグメンテーション：インプラントシステム、実績と予測, 2019-2024, 2024-2029F, 2034F
• 硝子体内インプラント
• 結膜下インプラント
• 眼球後インプラント
• 世界の眼ドラッグデリバリー市場、タイプ別サブセグメンテーション：粒子状ドラッグデリバリーシステム、実績と予測, 2019-2024, 2024-2029F, 2034F
• 微粒子
• リポソーム
• マイクロスフィア
• 世界の眼ドラッグデリバリー市場、タイプ別サブセグメンテーション：ナノ粒子ドラッグデリバリーシステム、実績と予測, 2019-2024, 2024-2029F, 2034F
• ナノエマルジョン
• 持続放出用ナノ粒子
• デンドリマー
• 世界の眼ドラッグデリバリー市場、タイプ別サブセグメンテーション：その他の技術、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイドロゲル
• ドラッグデリバリー付きコンタクトレンズ
• In situゲル形成システム

第7章 地域別・国別分析

• 世界の眼ドラッグデリバリー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の眼ドラッグデリバリー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 眼ドラッグデリバリー市場：競合情勢
• 眼ドラッグデリバリー市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Allergan Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Genentech Inc.
• Santen Pharmaceutical Co. Ltd.
• Akorn Inc.
• Valeant Pharmaceuticals International Inc.
• Aerie Pharmaceuticals Inc.
• Alimera Sciences Inc.
• Ocular Therapeutix Inc.
• Ophthotech Corporation
• Acucela Inc.
• Graybug Vision Inc.
• Amakem NV
• Kala Pharmaceuticals Inc.
• Icon Bioscience Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 眼ドラッグデリバリー市場2029：新たな機会を提供する国
• 眼ドラッグデリバリー市場2029：新たな機会を提供するセグメント
• 眼ドラッグデリバリー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ocular drug delivery is the process of administering medications or therapeutic agents directly to the eye. This method targets various ocular tissues to treat a range of eye conditions. It enhances drug bioavailability, ensures targeted treatment, and minimizes systemic side effects, resulting in improved patient outcomes for conditions such as glaucoma, infections, and retinal disorders.

The key technology types in ocular drug delivery include implantable ocular drug delivery systems, particulate drug delivery systems, nano-particle drug delivery systems, and others. Implantable ocular drug delivery systems are designed for controlled drug release and are constructed from polymers that either degrade over time or remain intact. They come in diverse formulations, including liposomes, nanoparticles, solutions, emulsions, suspensions, and ointments. These systems find application in treating a range of eye conditions such as glaucoma, diabetic retinopathy, dry eye syndrome, macular degeneration, cataracts, diabetic macular edema, among others. Various end-users, including hospitals, ophthalmic clinics, and ambulatory surgical centers, utilize these delivery systems for administering ocular drugs effectively.

The ocular drug delivery market research report is one of a series of new reports from The Business Research Company that provides ocular drug delivery market statistics, including ocular drug delivery industry global market size, regional shares, competitors with an ocular drug delivery market share, detailed ocular drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the ocular drug delivery industry. This ocular drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ocular drug delivery market size has grown strongly in recent years. It will grow from $18.14 billion in 2024 to $19.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to a rise in ocular diseases, aging population trends, advancements in pharmaceutical formulations, clinical advancements in ophthalmology, prevalence of diabetes-related eye conditions

The ocular drug delivery market size is expected to see strong growth in the next few years. It will grow to $27.18 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the rising incidence of age-related eye diseases, focus on personalized medicine in ophthalmology, increased investment in ophthalmic research, demand for prolonged drug release, and global initiatives for eye health. Major trends in the forecast period include the integration of smart drug delivery devices, personalized medicine in ocular drug formulations, the development of topical ophthalmic therapies, and collaborations for cross-industry innovations.

The anticipated growth in the ocular drug delivery market is expected to be propelled by the increasing prevalence of eye disorders. Eye disorders encompass a broad spectrum of conditions affecting the eyes, vision, or surrounding eye structures. Ocular drug delivery plays a pivotal role by delivering medications directly to the targeted site, optimizing therapeutic efficacy, minimizing systemic adverse effects, and addressing various eye disorders. For example, global estimates from the World Health Organization in March 2023 indicate that 2.2 billion people worldwide will experience near- or far-sighted impairment. Cataracts (94 million cases) and uncorrected refractive problems (88.4 million cases) stand out as the primary causes of visual impairment. Additionally, conditions such as glaucoma (7.7 million cases), corneal opacities (4.2 million cases), diabetic retinopathy (3.9 million cases), and trachoma (2 million cases) contribute significantly to vision loss. The increasing prevalence of eye disorders is thus a key driver for the growth of the ocular drug delivery market.

The increasing geriatric population is anticipated to drive the growth of the ocular drug delivery market in the future. The geriatric population typically includes individuals aged 65 and older. With age, the prevalence of eye diseases such as age-related macular degeneration, glaucoma, and cataracts rises. Fortunately, advancements in ocular drug delivery are providing effective treatment options for these conditions in older adults. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, projected that the number of Americans aged 65 and older will increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Additionally, this age group's share of the total population is expected to grow from 17% to 23% during the same timeframe. Thus, the expanding geriatric population is propelling the ocular drug delivery market.

Product innovation stands out as a prominent trend gaining traction in the ocular drug delivery market, with companies making significant efforts to introduce novel products and technologies to maintain their competitive edge. An example of this trend is evident in the initiatives of Alcon AG, a Swiss pharmaceutical and medical device company specializing in eye care products. In March 2023, Alcon launched TOTAL30 for astigmatism and SYSTANE HYDRATION for dry eye and ocular health. TOTAL30, the first Toric lens of its kind, combines Water Gradient and Celligent Technology to mimic the ocular surface's structure, providing superior performance in comfort, stability, and visual acuity. SYSTANE HYDRATION PF, an ocular health eye drop, employs HydroBoost technology to restore moisture, prevent irritation, and offer relief from dry eye symptoms.

Major players in the ocular drug delivery market are particularly focused on innovative solutions, including ophthalmic solutions targeting the signs and symptoms of dry eye disease (DED). An ophthalmic solution is a liquid medication applied directly to the eye for treating or preventing various eye conditions. For instance, Bausch + Lomb, a Canada-based pharmaceutical company specializing in ophthalmic products, launched Miebo, a perfluorohexyloctane ophthalmic solution, in the United States in September 2023. This prescription eye drop, administered four times a day, is water-, preservative-, and steroid-free, designed to reduce tear evaporation at the ocular surface and alleviate the signs and symptoms of dry eye disease.

In June 2022, Novartis AG, a Switzerland-based provider of innovative science and digital technologies for medical treatments, made a strategic move by acquiring Kedalion Therapeutics Inc. and its innovative ocular delivery platform for an undisclosed amount. This acquisition is expected to enhance Novartis's ophthalmic portfolio, allowing the company to deliver customer- and patient-centric advancements in ocular treatments. Novartis's commitment to reimagining medicine and improving medication delivery and patient experience is underscored by this acquisition. Kedalion Therapeutics Inc., the acquired entity, is a US-based developer and commercializer of transformative topical ophthalmic therapies.

Major companies operating in the ocular drug delivery market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Akorn Inc., Valeant Pharmaceuticals International Inc., Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., Ophthotech Corporation, Acucela Inc., Graybug Vision Inc., Amakem NV, Kala Pharmaceuticals Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Therapeutics Inc., Senju Pharmaceutical Co. Ltd., Spark Therapeutics Inc., Carl Zeiss Meditec AG, EyeGate Pharmaceuticals Inc.

North America was the largest region in the ocular drug delivery market in 2024. The regions covered in the ocular drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ocular drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ocular drug delivery market includes revenues earned by entities such as eye drops, eye gels, eye powders, and ocular injections. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ocular Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ocular drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Implantable Ocular Drug Delivery Systems; Particulate Drug Delivery Systems; Nano-Particle Drug Delivery System; Other Technologies
• 2) By Formulation: Liposomes And Nanoparticles; Solution; Emulsion; Suspension; Ointment
• 3) By Disease: Glaucoma; Diabetic Retinopathy; Dry Eye Syndrome; Macular Degeneration; Cataract; Diabetic Macular Edema; Other Diseases
• 4) By End User: Hospitals; Ophthalmic Clinics; Ambulatory Surgical Centers
• Subsegments:
• 1) By Implantable Ocular Drug Delivery Systems: Intravitreal Implants; Subconjunctival Implants; Retrobulbar Implants
• 2) By Particulate Drug Delivery Systems: Microparticles; Liposomes; Microspheres
• 3) By Nano-Particle Drug Delivery Systems: Nanoemulsions; Nanoparticles For Sustained Release; Dendrimers
• 4) By Other Technologies: Hydrogels; Contact Lenses With Drug Delivery; In situ Gel-Forming Systems
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Novartis AG; Allergan Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ocular Drug Delivery Market Characteristics

3. Ocular Drug Delivery Market Trends And Strategies

4. Ocular Drug Delivery Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Ocular Drug Delivery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ocular Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ocular Drug Delivery Market Growth Rate Analysis
• 5.4. Global Ocular Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ocular Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ocular Drug Delivery Total Addressable Market (TAM)

6. Ocular Drug Delivery Market Segmentation

• 6.1. Global Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implantable Ocular Drug Delivery Systems
• Particulate Drug Delivery Systems
• Nano-Particle Drug Delivery System
• Other Technologies
• 6.2. Global Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liposomes And Nanoparticles
• Solution
• Emulsion
• Suspension
• Ointment
• 6.3. Global Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glaucoma
• Diabetic Retinopathy
• Dry Eye Syndrome
• Macular Degeneration
• Cataract
• Diabetic Macular Edema
• Other Diseases
• 6.4. Global Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• 6.5. Global Ocular Drug Delivery Market, Sub-Segmentation Of Implantable Ocular Drug Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravitreal Implants
• Subconjunctival Implants
• Retrobulbar Implants
• 6.6. Global Ocular Drug Delivery Market, Sub-Segmentation Of Particulate Drug Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microparticles
• Liposomes
• Microspheres
• 6.7. Global Ocular Drug Delivery Market, Sub-Segmentation Of Nano-Particle Drug Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanoemulsions
• Nanoparticles For Sustained Release
• Dendrimers
• 6.8. Global Ocular Drug Delivery Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogels
• Contact Lenses With Drug Delivery
• In situ Gel-Forming Systems

7. Ocular Drug Delivery Market Regional And Country Analysis

• 7.1. Global Ocular Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ocular Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ocular Drug Delivery Market

• 8.1. Asia-Pacific Ocular Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ocular Drug Delivery Market

• 9.1. China Ocular Drug Delivery Market Overview
• 9.2. China Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ocular Drug Delivery Market

• 10.1. India Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ocular Drug Delivery Market

• 11.1. Japan Ocular Drug Delivery Market Overview
• 11.2. Japan Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ocular Drug Delivery Market

• 12.1. Australia Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ocular Drug Delivery Market

• 13.1. Indonesia Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ocular Drug Delivery Market

• 14.1. South Korea Ocular Drug Delivery Market Overview
• 14.2. South Korea Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ocular Drug Delivery Market

• 15.1. Western Europe Ocular Drug Delivery Market Overview
• 15.2. Western Europe Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ocular Drug Delivery Market

• 16.1. UK Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ocular Drug Delivery Market

• 17.1. Germany Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ocular Drug Delivery Market

• 18.1. France Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ocular Drug Delivery Market

• 19.1. Italy Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ocular Drug Delivery Market

• 20.1. Spain Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ocular Drug Delivery Market

• 21.1. Eastern Europe Ocular Drug Delivery Market Overview
• 21.2. Eastern Europe Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ocular Drug Delivery Market

• 22.1. Russia Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ocular Drug Delivery Market

• 23.1. North America Ocular Drug Delivery Market Overview
• 23.2. North America Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ocular Drug Delivery Market

• 24.1. USA Ocular Drug Delivery Market Overview
• 24.2. USA Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ocular Drug Delivery Market

• 25.1. Canada Ocular Drug Delivery Market Overview
• 25.2. Canada Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ocular Drug Delivery Market

• 26.1. South America Ocular Drug Delivery Market Overview
• 26.2. South America Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ocular Drug Delivery Market

• 27.1. Brazil Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ocular Drug Delivery Market

• 28.1. Middle East Ocular Drug Delivery Market Overview
• 28.2. Middle East Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ocular Drug Delivery Market

• 29.1. Africa Ocular Drug Delivery Market Overview
• 29.2. Africa Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ocular Drug Delivery Market Competitive Landscape And Company Profiles

• 30.1. Ocular Drug Delivery Market Competitive Landscape
• 30.2. Ocular Drug Delivery Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Allergan Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ocular Drug Delivery Market Other Major And Innovative Companies

• 31.1. Regeneron Pharmaceuticals Inc.
• 31.2. Bausch Health Companies Inc.
• 31.3. Genentech Inc.
• 31.4. Santen Pharmaceutical Co. Ltd.
• 31.5. Akorn Inc.
• 31.6. Valeant Pharmaceuticals International Inc.
• 31.7. Aerie Pharmaceuticals Inc.
• 31.8. Alimera Sciences Inc.
• 31.9. Ocular Therapeutix Inc.
• 31.10. Ophthotech Corporation
• 31.11. Acucela Inc.
• 31.12. Graybug Vision Inc.
• 31.13. Amakem NV
• 31.14. Kala Pharmaceuticals Inc.
• 31.15. Icon Bioscience Inc.

32. Global Ocular Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ocular Drug Delivery Market

34. Recent Developments In The Ocular Drug Delivery Market

35. Ocular Drug Delivery Market High Potential Countries, Segments and Strategies

• 35.1 Ocular Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ocular Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ocular Drug Delivery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer